Projects funded by the NCN

Testing of cation carrier derivatives as prospective therapeutic agents for the treatment of B-cell-derived malignancies...

Call: OPUS 18 , Panel: NZ5

Principal investigator: dr Beata Pyrzyńska

Warszawski Uniwersytet Medyczny, Wydział Lekarski

Strategy to overcome the "ionic checkpoint" and improve the antitumor immunotherapy.

Call: OPUS 29 , Panel: NZ7

Principal investigator: dr Beata Pyrzyńska

Warszawski Uniwersytet Medyczny

NK cells with inducible expression of CAR as novel immunotherapy increasing the efficacy of monoclonal antibodies.

Call: OPUS 12 , Panel: NZ5

Principal investigator: dr Beata Pyrzyńska

Warszawski Uniwersytet Medyczny, Wydział Lekarski

Influence of AKT signaling pathway on CD20 expression and antitumor activity of therapeutic monoclonal antibodies.

Call: OPUS 6 , Panel: NZ5

Principal investigator: dr Beata Pyrzyńska

Warszawski Uniwersytet Medyczny, I Wydział Lekarski